Davis Asset Management boosted its position by approximately $53 million in this provider of real estate-related services.
If you are wondering whether Travere Therapeutics is still good value after its big rebound, you are not alone. This stock has quickly moved from recovery story to serious contender on many watchlists ...
Case Files of a Texas Ranger follows James B. Holland as he uncovers chilling truths behind murders using real interrogations ...
Zacks Investment Research on MSN
What awaits these 4 biotech stocks that more than doubled in 2025
After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a ...
Rob Reiner, the son of a comedy giant who went on to become one, himself, as one of the preeminent filmmakers of his generation with movies such as “The Princess ...
Re “What the Epstein Emails Lay Bare,” by Anand Giridharadas (Opinion guest essay, Nov. 26): Mr. Giridharadas’s essay is one of the most important and well-written pieces of journalism I have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback